Shares of Structure Therapeutics are soaring Monday after the company reported positive topline data from a weight loss drug ...
Investors in Structure Therapeutics Inc (Symbol: GPCR) saw new options become available this week, for the July 2026 expiration. One of the key data points that goes into the price an option buyer is ...
Bitcoin traded near a critical resistance zone as chart data showed tightening structures across lower and higher timeframes, ...
Structure Therapeutics Inc (NASDAQ:GPCR) released results from the Phase 1b multiple ascending dose (MAD) study of GSBR-1290 in healthy, overweight, or obese individuals. GSBR-1290 is an oral GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback